<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), an EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>, occurs at high incidence in populations where <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> is holoendemic </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies in one such population suggested that <z:hpo ids='HP_0011009'>acute</z:hpo> P.falciparum <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> impairs EBV-specific T-cell surveillance, allowing expansion of EBV infected B-cells from which <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> derives </plain></SENT>
<SENT sid="2" pm="."><plain>We re-examined the situation in the same area, The Gambia, after a reduction in <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> endemicity </plain></SENT>
<SENT sid="3" pm="."><plain>Cellular immune responses to EBV were measured in children with uncomplicated <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> before (day 0) and after treatment (day 28), comparing EBV genome loads in blood and EBV-specific CD8(+) T-cell numbers (assayed by MHC Class I tetramers and IFNγ ELISPOTS) with those seen in age- and sex-matched healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>No significant changes were seen in EBV genome loads, percentage of EBV-specific CD8(+) T-cells and IFNγ producing T-cells in <z:hpo ids='HP_0011009'>acute</z:hpo> versus convalescent samples, nor any difference versus controls </plain></SENT>
<SENT sid="5" pm="."><plain>Regression assays performed also no longer detected any impairment of EBV-specific T-cell surveillance </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> uncomplicated <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> no longer alters EBV-specific immune responses in children in The Gambia </plain></SENT>
<SENT sid="7" pm="."><plain>Given the recent decline in <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> incidence in that country, we hypothesise that gross disturbance of the EBV-host balance may be a specific effect of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> only in children with a history of <z:hpo ids='HP_0011010'>chronic</z:hpo>/recurrent <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> challenge </plain></SENT>
</text></document>